Medical Journals

P53 and P73 Display Common and Distinct Requirements for Sequence Specific Binding to Dna.

Authors:
  • Lokshin Maria
  • Li Yingchun
  • Gaiddon Christian
  • Prives Carol

From: Department of Biological Sciences, Columbia University, New York, NY 10027, USA.

Nucleic acids research

  • Publish Date: 2007
  • ISSN: 1362-4962
  • Volume: 35
  • Issue: 1
  • Pages: 340-52
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Lokshin Maria, Li Yingchun, Gaiddon Christian, et al. P53 and P73 Display Common and Distinct Requirements for Sequence Specific Binding to Dna.. Nucleic Acids Res. 2007;35:340-52

Abstract

Although p53 and p73 share considerable homology in their DNA-binding domains, there have been few studies examining their relative interactions with DNA as purified proteins. Comparing p53 and p73beta proteins, our data show that zinc chelation by EDTA is significantly more detrimental to the ability of p73beta than of p53 to bind DNA, most likely due to the greater effect that the loss of zinc has on the conformation of the DNA-binding domain of p73. Furthermore, prebinding to DNA strongly protects p73beta but not p53 from chelation by EDTA suggesting that DNA renders the core domain of p73 less accessible to its environment. Further exploring these biochemical differences, a five-base sub-sequence was identified in the p53 consensus binding site that confers a greater DNA-binding stability on p73beta than on full-length p53 in vitro. Surprisingly, p53 lacking its C-terminal non-specific DNA-binding domain (p53Delta30) demonstrates the same sequence discrimination as does p73beta. In vivo, both p53 and p73beta exhibit higher transactivation of a reporter with a binding site containing this sub-sequence, suggesting that lower in vitro dissociation translates to higher in vivo transactivation of sub-sequence-containing sites.

Mesh Headings (Keywords): Base Sequence, Binding Sites, Cell Line, Chelating Agents, Consensus Sequence, Cysteine, DNA, DNA-Binding Proteins, Edetic Acid, Humans, Nuclear Proteins, Promoter Regions (Genetics), Protein Binding, Protein Structure, Tertiary, Sequence Deletion, Trans-Activation (Genetics), Tumor Suppressor Protein p53, Tumor Suppressor Proteins, Zinc


Check for Full Text / PubMed Unique Identifier (PMID): 17170001


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.